Skip to main content
. 2021 Jul 22;29(1):366–375. doi: 10.1245/s10434-021-10464-6

Table 3.

Chemotherapy and disease recurrence in patients with non-metastatic ductal adenocarcinoma undergoing standard (R0/R1) and extended distal pancreatectomy

Parameter Standard R0 [n = 23] Standard R1 [n = 56] Extended [n = 34] p-Value
Preoperative chemotherapy 0 (0) 5 (8.9) 1 (2.9) 0.33
Adjuvant chemotherapy 18 (78.3) 35 (62.5) 22 (64.7) 0.39
Recurrence 16 (69.6) 39 (69.6) 31 (91.2) 0.048
 Local 6 (26.1) 18 (32.1) 11 (32.4) 0.85
 Distant metastases 11 (47.8) 24 (42.9) 19 (55.9) 0.49
 Peritoneal carcinomatosis 2 (8.7) 7 (12.5) 10 (29.4) 0.08

Data are expressed as n (%)